Skip to evidence report

HPC.LMPP: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 909 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for HPC.LMPP
#Trait / studyIndividual trait IDMean IC score
1DKK1/PDGFA ratioGCST9031447583.24
2Platelet crit (UKB data field 30090)GCST9046809677.80
3Mosaic chromosomal alteration of the Y chromosomeGCST9016528975.23
4FLT3LG levelsGCST9046925073.73
5EDAR levelsGCST9046906869.19
6PlateletcritGCST9000240067.48
7MMP1/SERPINB6 ratioGCST9031546264.05
8Mean corpuscular volume | Blood countUKBB0000044963.29
9Platelet crit | Blood countUKBB0000064763.15
10EDAR/SDC4 ratioGCST9031458562.06
11Mean reticulocyte volumeGCST9000239661.33
12Anterior diffusion tensor imaging along the perivascular space indexGCST9045554361.16
13Mean reticulocyte volume (UKB data field 30260)GCST9046808860.65
14Platelet count during first trimester of pregnancyGCST9030222457.46
15Mean corpuscular volumeGCST9000239257.26
16CD244/EDAR ratioGCST9031376457.25
17Mean corpuscular haemoglobin | Blood countUKBB0000044756.62
18EDAR/TREML2 ratioGCST9031459256.43
19Mean reticulocyte volume | Blood countUKBB0000045155.80
20Platelet count | Blood countUKBB0000064655.32
21MMP1 levelsGCST9046991954.97
22Mean corpuscular volume (UKB data field 30040)GCST9046808653.81
23Mean corpuscular haemoglobin (UKB data field 30050)GCST9046808453.34
24Mean corpuscular volumeGCST9001874652.48
25Platelet countGCST9000240250.03
26Mean corpuscular hemoglobinGCST9000239047.97
27mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047545047.38
28Platelet countGCST9027864046.99
29Platelet count (UKB data field 30080)GCST9046809546.91
30platelet count (maximum, inv-norm transformed)GCST9047629646.73
31CRISP3 levelsGCST9046886646.70
32EDAR/TNFSF12 ratioGCST9031459146.60
33mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544645.29
34Mean corpuscular volumeGCST9000233545.24
35Mean corpuscular hemoglobinGCST9001874445.09
36Blood cell traits latent factor 8 (white cell)GCST9055925044.64
37Mean sphered cell volume (UKB data field 30270)GCST9046808944.62
38Mean sphered cell volume | Blood countUKBB0000045244.38
39Mean spheric corpuscular volumeGCST9000239744.05
40Mean corpuscular volumeGCST00460243.91
41mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed)GCST9047544243.59
42White blood cell count (basophil)GCST00461843.47
43OSCAR levelsGCST9047013142.63
44CCN2 levelsGCST9046858842.16
45Drive faster than motorway speed limit | Physical activityUKBB0000019441.82
46Basophil countGCST9000229341.80
47Basophil percentage of white cellsGCST00463141.64
48CPXM1/VEGFC ratioGCST9031422341.63
49white blood cell count (WBC, maximum, inv-norm transformed)GCST9047645141.32
50Total diffusion tensor imaging along the perivascular space indexGCST9045554640.97
51mean corpuscular volume (MCV, maximum, inv-norm transformed)GCST9047546640.33
52SEMA4D/TREML2 ratioGCST9031582340.29
53MMP1/MMP3 ratioGCST9031546140.09
54mean corpuscular volume (MCV, mean, inv-norm transformed)GCST9047547039.91
55Mean corpuscular hemoglobinGCST00463039.88
56platelet count (mean, inv-norm transformed)GCST9047629939.79
57IDP dMRI ProbtrackX L1 slf rGCST9000426839.52
58Platelet count during second trimester of pregnancyGCST9030222539.28
59TNFRSF10C levelsGCST9047090139.09
60SDC4 levelsGCST9047055938.97
61mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST9047547437.94
62PDGFA/VEGFC ratioGCST9031562237.84
63Non-cancer illness code, self-reported - type 2 diabetes | Medical conditionsUKBB0000052237.79
64CPXM1/SPARC ratioGCST9031422237.38
65Platelet distribution width (UKB data field 30110)GCST9046809737.15
66DKK1/SDC4 ratioGCST9031447937.09
67SDC4/SERPINE1 ratioGCST9031581936.63
68COCH levelsGCST9046881036.59
69Red blood cell countGCST9001875136.03
70PGLYRP1 levelsGCST9047021935.51
71platelet count (minimum, inv-norm transformed)GCST9047630235.40
72ANGPT1/APP ratioGCST9031326035.37
73Platelet distribution widthGCST9000240135.30
74Platelet countGCST9001874935.27
75CCN2/EDAR ratioGCST9031371135.08
76Basophil countGCST9001872634.66
77PlateletcritGCST00460734.66
78ITGB1BP2/PTPN6 ratioGCST9031521833.96
79EDAR/PSRC1 ratioGCST9031458433.96
80Platelet distribution width | Blood countUKBB0000064833.95
81CD63/EDAR ratioGCST9031386433.61
82DNA methylation Hannum age accelerationGCST9001428933.32
83LCN2 levelsGCST9046974733.31
84Red blood cell erythrocyte count (UKB data field 30010)GCST9046809833.30
85Subclinical hypothyroidism in pregnancyGCST9043519732.98
86CST3/DEFA1_DEFA1B ratioGCST9031429132.79
87Right-hemisphere somatomotor network to pallidum white-matter structural connectivityGCST9030279732.59
88CCN2/VEGFC ratioGCST9031371932.51
89CCL28 levelsGCST9046858032.48
90EDAR/SPARC ratioGCST9031458831.89
91HSBP1 levelsGCST9046948131.57
92HBEGF/SDC4 ratioGCST9031503731.19
93Platelet countGCST00460331.19
94Basophil percentage of granulocytesGCST00463430.90
95Heart failure, strictFING0000060630.82
96DorsalgiaFING0000047230.81
97red blood cell count (RBC, maximum, inv-norm transformed)GCST9047634530.80
98Mean corpuscular hemoglobinGCST9000232330.76
99Platelet count during third trimester of pregnancyGCST9030222630.68
100Telomere length (principal component 1)GCST9043514430.53
101Attention deficit hyperactivity disorderGCST9056844130.48
102CPXM1/MDK ratioGCST9031422130.42
103mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)GCST9047545430.30
104T1 FreeSurfer DK rh fusiform volumeGCST9038576330.29
105ENO2/ITGB1BP2 ratioGCST9031466130.29
106DRAXIN levelsGCST9046903830.16
107Red blood cell countGCST9000236430.15
108Operation code - bunion/hallus valgus surgery | OperationsUKBB0000055129.90
109LCN2/PGLYRP1 ratioGCST9031530629.34
110Leisure screen timeGCST9010433929.03
111mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST9047545828.80
112Nontoxic goitre/thyroid noduleFING0000088728.70
113CTF1/ITGB1BP2 ratioGCST9031430528.53
114PDGFA/SCARF1 ratioGCST9031561728.52
115Codeine or tramadol medicationFING0000031128.39
116SpondylosisFING0000132728.38
117Platelet distribution widthGCST00461628.28
118CRYGD levelsGCST9046887628.25
119Frequency of drinking alcohol | Alcohol useUKBB0000026028.25
120mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed)GCST9047546227.74
121Low back painFING0000073027.60
122Depression medicationsFING0000039927.40
123GALNT5 levelsGCST9046929827.35
124Nontoxic multinodular goitreFING0000088827.28
125Attention deficit hyperactivity disorderGCST00536227.21
126Blood cell traits latent factor 2 (red cell)GCST9055924426.80
127TREML2 levelsGCST9047096226.78
128CXCL11 levelsGCST9046892426.36
129FLT3/FLT3LG ratioGCST9031485926.21
130CXCL11/SDC4 ratioGCST9031433626.20
131CXCL6/DFFA ratioGCST9031435726.12
132Age at first sexual intercourseGCST9000004626.10
133ANGPT1/CPXM1 ratioGCST9031326226.10
134CAPS levelsGCST9046853926.02
135BTC levelsGCST9046847625.98
136Platelet count during postpartum periodGCST9030222825.78
137PDGFA/SPARC ratioGCST9031562025.73
138IDP dMRI ProbtrackX ISOVF ifo lGCST9000453725.59
139CD84/TREML2 ratioGCST9031391925.50
140Gestational thrombocytopeniaGCST9030223425.22
141Principal component-derived dietary pattern 45GCST9013305025.18
142Number of operations, self-reported | OperationsUKBB0000053925.11
143Mean platelet (thrombocyte) volume | Blood countUKBB0000045024.89
144red blood cell count (RBC, minimum, inv-norm transformed)GCST9047635324.73
145red blood cell count (RBC, mean, inv-norm transformed)GCST9047634924.73
146Osteoarthritis, localized (PheCode 740.1)GCST9047625424.65
147MPI/TACC3 ratioGCST9031549124.63
148CPXM1/DKK1 ratioGCST9031421824.60
149White blood cell countGCST9001875824.55
150Peak expiratory flow (PEF) | SpirometryUKBB0000063824.46
151white blood cell count (WBC, mean, inv-norm transformed)GCST9047645424.44
152SDC4/SELP ratioGCST9031581724.26
153PDGFA/SERPINE1 ratioGCST9031561824.22
154Lower back pain or/and sciaticaFING0000073123.93
155METAP1D/VASH1 ratioGCST9031542923.79
156Mean platelet volume during second trimester of pregnancyGCST9030223023.73
157Number of days/week walked 10+ minutes | Physical activityUKBB0000053523.65
158APP/HBEGF ratioGCST9031332423.63
159HBEGF levelsGCST9046943323.61
160Other intervertebral disk disorders | Other dorsopathiesUKBB0000061223.55
161CEACAM8/RNASE3 ratioGCST9031400423.35
162Other and unspecified tonsillitisFING0000095423.29
163CCL28/PDGFB ratioGCST9031369523.18
164ANGPT1/CCN2 ratioGCST9031326123.17
165Red blood cell countGCST00460123.15
166Bursitis (PheCode 726.3)GCST9047624023.14
167aparc-a2009s lh area S-temporal-supGCST9000336923.11
168Prescriptions - gliclazide | sulfonylurea,diabetesUKBB0000068423.06
169Mood [affective] disordersFING0000083623.03
170SPARC/TACC3 ratioGCST9031587222.99
171EDAR/F2R ratioGCST9031457722.88
172Mean platelet volume during first trimester of pregnancyGCST9030222922.85
173neutrophil (absolute count, maximum, inv-norm transformed)GCST9047552622.75
174Duration walking for pleasure | Physical activityUKBB0000020322.72
175PDGFB/SDC4 ratioGCST9031562622.69
176APP/CD40LG ratioGCST9031331922.63
177CDKN2D/ITGB1BP2 ratioGCST9031398722.61
178F2R/ITGB1BP2 ratioGCST9031473122.59
179CXCL11/CXCL13 ratioGCST9031433322.56
180Lupus erythematosusFING0000073922.47
181Red blood cell countGCST9000240322.36
182CRACR2A/IRAG2 ratioGCST9031422722.35
183TCN1 levelsGCST9047081922.33
184White blood cell countGCST9000237522.20
185CCL2 levelsGCST9046858122.11
186LCN2/RETN ratioGCST9031530822.08
187CD38 levelsGCST9046862822.02
188TNFSF12 levelsGCST9047091921.97
189LAT2/YES1 ratioGCST9031528221.95
190Number of sexual partners in opposite-sex sexual behaviorGCST9002648021.64
191Chronic diseases of tonsils and adenoidsFING0000028321.63
192CEACAM6 levelsGCST9046869721.52
193Platelet countGCST9000235821.45
194FADD/MGLL ratioGCST9031476821.44
195CCL5/TACC3 ratioGCST9031370721.41
196Clonal haematopoiesis of indeterminate potential (DNMT3A mutation)GCST9016527121.41
197CDKN2D/TACC3 ratioGCST9031399221.26
198Nerve, nerve root and plexus disordersFING0000086221.17
199ITGB1BP2/MED18 ratioGCST9031521321.16
200IDP dMRI TBSS L1 Superior longitudinal fasciculus RGCST9000411521.08
201CXCL11/DKK1 ratioGCST9031433421.04
202Clonal haematopoiesis of indeterminate potential (with or without mosaic chromosomal alteration)GCST9016526721.02
203MAVS/ZBTB16 ratioGCST9031540120.69
204EDAR/PRDX5 ratioGCST9031458320.65
205CPXM1/LGMN ratioGCST9031422020.61
206PRG2 levelsGCST9047032220.54
207neutrophil (absolute count, mean, inv-norm transformed)GCST9047552920.53
208Polyneuropathy in diabetes (PheCode 250.6)GCST9047568620.47
209Pain in jointFING0000113720.45
210Basophil countGCST9000229220.43
211Illnesses of siblings - Diabetes | Family historyUKBB0000035020.29
212ArthropathiesFING0000010720.26
213Whole body fat free mass (UKB data field 23101)GCST9042812020.24
214IPCEF1/SMAD1 ratioGCST9031518520.22
215DNM3 levelsGCST9046902220.22
216Activities undertaken to treat depression | DepressionUKBB0000001020.10
217BMI and adiposity (confirmatory factor analysis Factor 7)GCST9030934220.08
218Non-ischemic cardiomyopathyFING0000087320.05
219Birth weightGCST00755720.02
220Central pulse pressureGCST9026738719.95
221Frailty (Factor 2 - Unhealthy Lifestyle)GCST9062404819.94
222CD36 levelsGCST9046862719.94
223Psoriasis vulgarisGCST9001868719.92
224EDAR/F11R ratioGCST9031457619.92
225Retention of urineFING0000125719.85
226Prescriptions - ACE inhibitor|anti-hypertensiveUKBB0000065719.82
227COL2A1 levelsGCST9046881619.78
228rfMRI connectivity (ICA100 edge 995)GCST9000584819.77
229T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16)GCST9032057919.74
230Right-hemisphere somatomotor network to hippocampus white-matter structural connectivityGCST9030279819.73
231CD244/GP1BA ratioGCST9031376619.56
232VEGFA levelsGCST9047103419.50
233Sleep apnoeaFING0000130919.48
234CCL11/CCL2 ratioGCST9031367219.42
235CEP43/WASF1 ratioGCST9031402319.21
236Number of sexual partners in opposite-sex sexual behaviorGCST9002648219.19
237ATP5IF1/DECR1 ratioGCST9031338219.17
238Other diseases of intestinesFING0000100119.11
239DKK1/SERPINE1 ratioGCST9031448019.09
240CD300C/MANSC1 ratioGCST9031379119.09
241Red blood cell (erythrocyte) count | Blood countUKBB0000074719.00
242CRH levelsGCST9046886218.98
243SDC4/SEMA4D ratioGCST9031581818.92
244rfMRI connectivity ICA-features 3GCST9000634118.87
245IDP dMRI ProbtrackX L1 slf lGCST9000426718.79
246Other joint disordersFING0000106418.77
247Monocyte countGCST9001874718.76
248KIFBP/TACC3 ratioGCST9031524918.68
249GALNT10/TNFSF12 ratioGCST9031491618.60
250Pain in limb (PheCode 773)GCST9047627018.57
251mean platelet volume (MPV, maximum, inv-norm transformed)GCST9047551718.54
252CDKN1A/TACC3 ratioGCST9031397518.51
253ANGPT1/PDGFA ratioGCST9031326618.50
254Alcohol drinker status: current vs never (UKB data field 20117)GCST9013292418.48
255Prescriptions - sulfonylurea|diabetesUKBB0000070318.44
256AZU1/RNASE3 ratioGCST9031342818.35
257Bread type - White | DietUKBB0000010618.35
258PRG3 levelsGCST9047032318.31
259DKK1/VEGFA ratioGCST9031448318.26
260Plasma X-24947 levels in chronic kidney diseaseGCST9026681618.26
261Middle diffusion tensor imaging along the perivascular space indexGCST9045554418.21
262Spread type: Butter and margarine spreads vs oil-based spreads (UKB data field 1428)GCST9013295118.19
263Hypothyroidism, drug reimbursementFING0000065518.15
264Tea with sugar likingGCST9009485718.15
265CD69/SNAP23 ratioGCST9031388618.12
266TNFRSF14 levelsGCST9047090718.08
267CD300C/HAVCR2 ratioGCST9031378918.04
268ANXA3/EDAR ratioGCST9031328017.99
269RETN levelsGCST9047045717.97
270Sleep apnea (MTAG)GCST9026736217.88
271PVALB levelsGCST9047039317.88
272CNTNAP2/DPP6 ratioGCST9031416817.86
273SPARC/TJAP1 ratioGCST9031587317.76
274JAM3 levelsGCST9046966017.75
275Pain (limb, back, neck, head abdominally)FING0000113517.71
276Cerebrospinal fluid sulfate* levelsGCST9031805617.67
277ANGPT1/DKK1 ratioGCST9031326317.57
278Time spent watching television (TV) | Physical activityUKBB0000082117.56
279Number of non-cancer illnesses (standard GWA)GCST9026729017.55
280Nonspecific chest pain (PheCode 418)GCST9047594717.53
281Sleep apnoea, including avohilmoFING0000131017.43
282Principal component-derived dietary pattern 2GCST9013300717.37
283CLEC11A levelsGCST9046876417.36
284CST7 levelsGCST9046889717.30
285PIK3AP1 levelsGCST9047023317.20
286SIRPB1 levelsGCST9047064017.16
287Soft tissue disordersFING0000131617.15
288Biological Mother: High blood pressureGCST9047549017.09
289MAP2 levelsGCST9046985317.09
290DEFA1 or DEFA1B levelsGCST9046897917.07
291CCN2/DKK1 ratioGCST9031371017.06
292DAG1/F2R ratioGCST9031437416.98
293Viral hepatitis C (PheCode 70.3)GCST9047555316.98
294Mean platelet volume during third trimester of pregnancyGCST9030223116.96
295AARSD1/PIK3AP1 ratioGCST9031312916.94
296Basophil percentage of white cellsGCST9000238016.92
297CA4/TNFSF12 ratioGCST9031358916.90
298Left-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST9030268716.88
299SNAP23/ZBTB16 ratioGCST9031585816.88
300Ankle spacing width (left) | Bone-densitometry of heelUKBB0000003316.76
301F-caffeinated/sweet liking (derived food-liking factor)GCST9009472016.75
302Sleep apnea syndromeGCST9026736116.69
303CXCL11/VTA1 ratioGCST9031433716.68
304Vascular/heart problems diagnosed by doctor - High blood pressure | Medical conditionsUKBB0000089816.67
305CASP3/SERPINE1 ratioGCST9031364316.66
306Right-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivityGCST9030281616.66
307CRELD2/F2R ratioGCST9031425416.63
308IL2RA levelsGCST9046958516.62
309Mean platelet volumeGCST9000239516.59
310Mean reticulocyte volumeGCST9002597516.58
311Blood cell traits latent factor 10 (platelet)GCST9055925216.49
312EBAG9/FKBP5 ratioGCST9031456416.47
313EDAR/TXNDC5 ratioGCST9031459316.46
314rfMRI connectivity ICA-features 6GCST9000634416.32
315Cerebrospinal fluid 3-hydroxyhexanoate levelsGCST9031810816.31
316DAG1/PDGFA ratioGCST9031437816.28
317CNTNAP2/DPP10 ratioGCST9031416716.19
318CALCOCO1/MAP3K5 ratioGCST9031360516.19
319Avocado likingGCST9009469416.16
320Average weekly beer plus cider intake | AlcoholUKBB0000008216.07
321ANGPT1/EGF ratioGCST9031326416.06
322Non-cancer illness code, self-reported - hypertension | Medical conditionsUKBB0000051716.05
323Soy sauce likingGCST9009484416.04
324Tonsillectomy and adenotomyFING0000136716.02
325Mean platelet thrombocyte volume (UKB data field 30100)GCST9046808715.99
326CLIP2/NT5C3A ratioGCST9031412915.93
327Monocyte countGCST9000234115.90
328BCAM/ICAM4 ratioGCST9031347215.90
329FCER2/TREML2 ratioGCST9031479215.88
330Pain (PheCode 338)GCST9047583615.87
331Alcohol drinker status: current or former vs never (UKB data field 20117)GCST9013292315.87
332C3 levelsGCST9028104115.83
333CLC levelsGCST9046876215.82
334EGLN1/PIK3AP1 ratioGCST9031461915.82
335CDKN2D/MANF ratioGCST9031398915.75
336Types of transport used (excluding work) - Public transport | Physical activityUKBB0000087815.72
337Depression or dysthymiaFING0000040015.71
338Other symptoms of respiratory system (PheCode 512)GCST9047603915.70
339Other dorsopathies, not elsewhere classifiedFING0000104115.70
340Viral hepatitis (PheCode 70)GCST9047555215.70
341Pain in joint (PheCode 745)GCST9047626215.69
342Attention deficit hyperactivity disorder (adjusted for age, sex)GCST9027514715.68
343Brain glioblastoma, excluding all cancers (controls excluding all cancers)FING0000022515.68
344Ankle spacing width (right) | Bone-densitometry of heelUKBB0000003415.66
345white blood cell count (WBC, minimum, inv-norm transformed)GCST9047645715.60
346Volume of right cortical nucleusGCST9047503015.60
347CXCL6 levelsGCST9046893315.57
348Leg fat mass (right) | Impedance measuresUKBB0000039015.53
349Other diseases of upper respiratory tractFING0000101215.48
350CCN2/HBEGF ratioGCST9031371315.43
351Weight (UKB data field 21002)GCST9046818315.42
352ENO2/TXNDC5 ratioGCST9031467115.39
353CPXM1/HBEGF ratioGCST9031421915.37
354Biological Mother: Cancer, SkinGCST9047548715.36
355Basophil countGCST9002599715.31
356PSRC1 levelsGCST9047036515.29
357FOXO1/MAP4K5 ratioGCST9031487215.27
358Age at first sexual intercourseGCST9000004715.24
359Birth weight known - No | Early life factorsUKBB0000009615.22
360VSTM1 levelsGCST9047105515.20
361Immature fraction of reticulocytesGCST00462815.20
362Mean platelet volumeGCST00459915.18
363AXIN1/DOK2 ratioGCST9031340615.17
364F2R/TNFRSF14 ratioGCST9031473915.13
365GRAP2/SRC ratioGCST9031498915.12
366SERPINE1/SMAD1 ratioGCST9031583315.11
367CLEC4C levelsGCST9046877215.05
368Annual healthcare costGCST9029260415.05
369MGLL/PLA2G4A ratioGCST9031543915.00
370ITGB1BP2 levelsGCST9046964214.99
371Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418)GCST9013298614.96
372IDP dMRI TBSS L2 FornixGCST9000412814.95
373CFC1 levelsGCST9046872414.95
374ATP5IF1/METAP1D ratioGCST9031339114.95
375Thyrotoxicosis with toxic multinodular goitreFING0000136214.89
376CLEC1B/DKK1 ratioGCST9031408814.89
377CXCL3/CXCL5 ratioGCST9031434414.87
378Tea difference likingGCST9009485514.87
379Alcohol consumptionGCST9013300314.85
380CCN2/SPINT2 ratioGCST9031371614.83
381JAM2/TNFRSF14 ratioGCST9031524014.82
382NUDT5/TXNRD1 ratioGCST9031558214.81
383Spondylopathies (FG)FING0000132614.79
384TNFRSF13C/TNFSF13B ratioGCST9031593414.78
385FABP5/PPCDC ratioGCST9031476314.75
386DEFA1_DEFA1B/PTGDS ratioGCST9031445514.75
387AXIN1/MAP2K6 ratioGCST9031341314.71
388IDP dMRI TBSS OD FornixGCST9000440714.70
389Oral glucose tolerance test-2hGCST9029779014.68
390DAG1/DKK1 ratioGCST9031437314.65
391PPP1R2/TMSB10 ratioGCST9031572114.61
392CD69/CHMP1A ratioGCST9031386814.60
393CD22/SEMA7A ratioGCST9031375914.54
394Hypertension | circulatory systemUKBB0000033414.51
395Waist circumference (UKB data field 48)GCST9046818214.51
396SELL levelsGCST9047056714.51
397SIGLEC8 levelsGCST9047063614.46
398PDGFA levelsGCST9047018814.45
399PDGFA/SNAP23 ratioGCST9031561914.44
400Essential hypertension | circulatory systemUKBB0000020914.44
401Breast cancerGCST00723614.43
402White blood cell countGCST00461014.41
403DKK1 levelsGCST9046899714.41
404Attention deficit hyperactivity disorder (ADuLT model adjusted for sex)GCST9027513614.40
405Cough on most days | Medical informationUKBB0000015314.39
406CCN2/TPP1 ratioGCST9031371814.39
407F-sweetened coffee drink liking (derived food-liking factor)GCST9009485314.38
408Red blood cell countGCST9027864114.36
409Heart failure and bmi 25plusFING0000060314.35
410CD22/FOLR2 ratioGCST9031375814.32
411CRADD/FADD ratioGCST9031423714.30
412Blood cell traits latent factor 18 (platelet)GCST9055926014.30
413monocyte (absolute count, maximum, inv-norm transformed)GCST9047549914.28
414GOLGA3 levelsGCST9046937514.28
415Treatment/medication code - ramipril | MedicationsUKBB0000085614.27
416IDP T1 FAST ROIs L cerebellum VGCST9000256414.26
417Right-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivityGCST9030280514.26
418Length of mobile phone use | Electronic device useUKBB0000040314.26
419FCRL1/TREML2 ratioGCST9031479714.23
420ITGB5/VSIR ratioGCST9031523514.17
421Age when finished full-time education (standard GWA)GCST9026728014.14
422Number of treatments/medications taken | MedicationsUKBB0000054214.12
423ITGB1BP2 levelsGCST9001205814.11
424EDAR/ENO2 ratioGCST9031457414.08
425Arm fat percentage (left) | Impedance measuresUKBB0000004514.06
426Pain type(s) experienced in last month - None of the above | PainUKBB0000063114.06
427T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119)GCST9032093814.05
428DepressionFING0000039814.04
429IDP dMRI ProbtrackX ICVF str rGCST9000439914.04
430SCRN1 levelsGCST9047055613.97
431Right-hemisphere control network to amygdala white-matter structural connectivityGCST9030284113.96
432Breathing problems during period of job | Employment historyUKBB0000011113.94
433EBAG9/EDAR ratioGCST9031456313.93
434CLEC1B/NSFL1C ratioGCST9031409913.89
435Basophill percentage | Blood countUKBB0000008713.86
436Been in a confiding relationship as an adult | Traumatic eventsUKBB0000008813.86
437Snoring | SleepUKBB0000078413.84
438SPINT2 levelsGCST9047072813.84
439Osteoarthrosis (PheCode 740)GCST9047625313.84
440SEMA4D levelsGCST9047057313.79
441Neutrophil countGCST9000235213.76
442DNAJC6 levelsGCST9046901713.69
443Principal component-derived dietary pattern 8GCST9013301313.68
444REST UKBBICA NODEamps25 0005GCST9038548813.68
445CD244/TREML2 ratioGCST9031376713.65
446PEAR1/TREML2 ratioGCST9031564513.65
447CPXM1 levelsGCST9046884913.58
448SERPINE2 levelsGCST9047059713.58
449CD69/CDKN2D ratioGCST9031386613.56
450Biological Grandparent (paternal): Diabetes / SugarGCST9047554913.56
451TRIAP1 levelsGCST9047096313.56
452SFTPA2 levelsGCST9047061313.55
453White blood cell (leukocyte) count | Blood countUKBB0000091313.52
454CXCL5/SPARC ratioGCST9031435513.51
455SERPINE1/SPARC ratioGCST9031583413.50
456Basal metabolic rate (UKB data field 23105)GCST9046815913.49
457CLEC1B/VTA1 ratioGCST9031410713.48
458Humerus length to body height ratioGCST9027025913.47
459IDP dMRI TBSS FA FornixGCST9000388213.44
460CD58/SIRPB1 ratioGCST9031385513.42
461TFF1/TFF2 ratioGCST9031591413.33
462Any mental disorderFING0000010013.30
463EDAR/TMSB10 ratioGCST9031459013.28
464ACY1/SCLY ratioGCST9031316513.27
465DIPK2B levelsGCST9046899613.27
466Irregular mensesFING0000070113.26
467HTRA2/TRIAP1 ratioGCST9031509913.25
468Patient classification on admission (recoded) - Inpatient | Summary AdministrationUKBB0000063713.25
469Paradoxical eczema in biologic-treated plaque psoriasisGCST9016255013.25
470TACC3/TRIAP1 ratioGCST9031590113.22
471EGFL7 levelsGCST9046908313.19
472Artrosis, including avohilmoFING0000011213.19
473LYN/TACC3 ratioGCST9031535013.18
474GP6/TMSB10 ratioGCST9031497513.17
475CLEC1B/HEXIM1 ratioGCST9031409313.17
476SnoringGCST00976013.14
477CSF3R levelsGCST9046888513.13
478PAPPA levelsGCST9047015713.13
479Overall health rating | General healthUKBB0000062113.13
480Right-hemisphere somatomotor network to thalamus white-matter structural connectivityGCST9030279413.12
481Other disorders of the musculoskeletal system and connective tissueFING0000103813.10
482ATP5IF1/HSPA1A ratioGCST9031338813.10
483Basophil countGCST9000237913.10
484Sleep apnea (MTAG) (adjusted for BMI)GCST9026736413.09
485Illnesses of siblings - None of the above (group 1) | Family historyUKBB0000035313.09
486TGFB1 levelsGCST9047084313.09
487CD40LG/EDAR ratioGCST9031381813.08
488ANXA4/FADD ratioGCST9031329113.05
489Age first had sexual intercourse | Sexual factorsUKBB0000001413.04
490Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030281113.04
491NTF4 levelsGCST9047009512.99
492Other localized connective tissue disordersFING0000106612.98
493Weight | Body size measuresUKBB0000090912.98
494Other and/or unspecified nontoxic goitreFING0000095812.96
495Leg fat mass (left) | Impedance measuresUKBB0000038912.94
496X-13435 levelsGCST9024381112.94
497CLEC1B/RWDD1 ratioGCST9031410212.93
498Treatment or medication use - metformin (UKB data field 20003_1140884600)GCST9004224512.92
499Weight | Impedance measuresUKBB0000091012.91
500Arm fat percentage (right) | Impedance measuresUKBB0000004612.90
501Other embolism and thrombosisFING0000104312.89
502SNAP29/TJAP1 ratioGCST9031586112.88
503Sleep disorders (PheCode 327)GCST9047582312.87
504SCPEP1 levelsGCST9047055312.86
505CCDC50 levelsGCST9046856112.86
506Neutrophil countGCST9001874812.86
507Anxiety disorders (more control exclusions)FING0000009812.86
508Venous thromboembolismFING0000142712.82
509Alcohol intake versus 10 years previously | AlcoholUKBB0000002412.82
510CCN2/ENO2 ratioGCST9031371212.81
511FHIT/MAX ratioGCST9031481812.80
512CETN2/PRTFDC1 ratioGCST9031403012.80
513Gonarthrosis, primary, with knee surgeryFING0000058612.79
514CXCL5/SERPINE1 ratioGCST9031435412.74
515GFER/VASH1 ratioGCST9031492212.72
516CXCL5/EDAR ratioGCST9031434912.68
517FOXO1/NFATC1 ratioGCST9031487312.67
518CD40LG levelsGCST9046863212.67
519DAG1/SCARF1 ratioGCST9031438112.66
520Salty food likingGCST9009482812.64
521DorsopathiesFING0000047312.63
522IL15/NCR1 ratioGCST9031515012.60
523monocyte (absolute count, mean, inv-norm transformed)GCST9047550212.59
524GP5 levelsGCST9046938312.59
525EDAR/IPCEF1 ratioGCST9031457812.58
526CXCL12/TIMP3 ratioGCST9031433812.57
527CASP3/PDGFA ratioGCST9031363712.56
528Liver iron contentGCST9001667412.56
529ENO2/RWDD1 ratioGCST9031466712.51
530Prescriptions - calcium channel blocker|dihydropyridine|anti-hypertensiveUKBB0000067312.50
531DAB2/FKBP5 ratioGCST9031436312.50
532Bread type: White (UKB data field 1448_1)GCST9013296412.49
533Soya milk likingGCST9009484512.48
534SLAMF8 levelsGCST9047065212.46
535ANXA3/HCLS1 ratioGCST9031328212.45
536EDAR/EGF ratioGCST9031457312.45
537MECR levelsGCST9046987912.44
538SpondylopathiesFING0000132512.41
539FHIT/PMVK ratioGCST9031482212.39
540Platelet count at deliveryGCST9030222712.37
541LCN2/S100A12 ratioGCST9031530912.35
542Lymphocyte percentage of white cellsGCST9000238912.35
543SERPINB6 levelsGCST9047059112.34
544Number of incorrect matches in round | Pairs matchingUKBB0000053812.31
545IDP dMRI TBSS L3 FornixGCST9000417612.30
546FGF2/HBEGF ratioGCST9031481112.28
547CRADD/EDAR ratioGCST9031423512.27
548X-12749 levelsGCST9024377012.27
549CRYBB1 levelsGCST9046887412.26
550neutrophil (absolute count, minimum, inv-norm transformed)GCST9047553212.26
551Salt added to food | DietUKBB0000076212.25
552Other soft tissue disorders, not elsewhere classifiedFING0000109912.25
553Sedentary behavior at workGCST9010434512.23
554CD84/SDC4 ratioGCST9031391612.23
555Alcohol drinker status - Never | AlcoholUKBB0000002212.15
556Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448)GCST9013296712.11
557DTI TBSS L2 Anterior limb of internal capsule LGCST9038449312.09
558BCR/NFATC1 ratioGCST9031349612.09
559Major depressive disorder (probable)GCST00590412.06
560CLEC1B/SNAP29 ratioGCST9031410312.05
561IDP dMRI TBSS MD FornixGCST9000403212.03
562SCARF1 levelsGCST9047053612.03
563Illnesses of father - Diabetes | Family historyUKBB0000034112.00
564ADAM8 levelsGCST9046822011.97
565Use of hypnotics and sedativesFING0000141111.96
566ANGPT1/SERPINE1 ratioGCST9031326911.96
567Lymphocyte percentage (UKB data field 30180)GCST9046808311.96
568CD69/EDAR ratioGCST9031387511.90
569MAX/STK24 ratioGCST9031540411.89
570Chronic airway obstruction (PheCode 496)GCST9047602711.89
571APP/CCL28 ratioGCST9031331711.88
572Brussel sprout likingGCST9009471411.87
573NRCAM/PCDH17 ratioGCST9031555311.84
574Vigorous physical activityGCST00609811.83
575Nap during day | SleepUKBB0000049211.82
576SnoringGCST00976311.82
577Illness, injury, bereavement, stress in last 2 years - None of the above | Mental healthUKBB0000033911.81
578CD22 levelsGCST9046861011.79
579Trunk fat mass | Impedance measuresUKBB0000086311.79
580ROBO1 levelsGCST9047048911.78
581SELP levelsGCST9047056911.78
582WFDC1 levelsGCST9047107411.78
583Arm fat mass (right) | Impedance measuresUKBB0000004411.78
584Medication use (vasodilators used in cardiac diseases)GCST9001876311.76
585DNA methylation PhenoAge accelerationGCST9001429211.76
586Poultry consumptionGCST9013299611.75
587FLT1/VEGFA ratioGCST9031485811.74
588Whole body fat mass | Impedance measuresUKBB0000091411.72
589MITD1/RHOC ratioGCST9031545311.70
590HIP1R levelsGCST9046945311.66
591CLEC1B/LGALS8 ratioGCST9031409611.66
592FKBP4/RWDD1 ratioGCST9031484011.65
593Treatment/medication code - gliclazide | MedicationsUKBB0000084611.65
594Gastro-oesophageal reflux diseaseFING0000056411.64
595TP53BP1 levelsGCST9047093611.63
596MAP4K5 levelsGCST9046985511.62
597Monocyte count | Blood countUKBB0000047911.62
598Parental longevity (father's age at death)GCST00670011.62
599Leg predicted mass (left) | Impedance measuresUKBB0000039611.60
600Birth weight known - Yes - pounds and ounces | Early life factorsUKBB0000009711.59
601Educational attainment (confirmatory factor analysis Factor 10)GCST9030934411.57
602CXCL10/CXCL11 ratioGCST9031433011.57
603Prescriptions - biguanides|diabetesUKBB0000067111.55
604Episodal and paroxysmal disordersFING0000051411.54
605Occupational attainmentGCST9010225311.53
606Prescriptions - metformin | biguanides,diabetesUKBB0000069211.53
607Frequency of friend/family visits | Social supportUKBB0000026211.52
608IL15 levelsGCST9046955611.51
609Hypermetropia (PheCode 367.8)GCST9047588211.50
610BCR/VASH1 ratioGCST9031349911.50
611VEGFC levelsGCST9047103611.50
612FCRL1 levelsGCST9046920511.49
613Frequency of stair climbing in last 4 weeks | Physical activityUKBB0000026611.47
614ENG/NCAM2 ratioGCST9031464711.46
615TPD52L2 levelsGCST9047094211.45
616BCAM/PCDH17 ratioGCST9031347511.44
617Mean corpuscular hemoglobin concentrationGCST9000232811.43
618Neutrophill count | Blood countUKBB0000049711.41
619Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivityGCST9030267411.41
620BA-exvivo rh volume MTGCST9000286011.39
621Paracetamol of NSAID medicationFING0000114511.39
622Taking other prescription medications | MedicationUKBB0000081311.33
623RETN levelsGCST9001203411.32
624Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST9043520311.31
625CXCL5/PPIB ratioGCST9031435211.31
626Myeloid white cell countGCST00462611.31
627ERBIN/LYN ratioGCST9031469411.30
628Septal defectsFING0000129311.30
629Lymphocyte percentage | Blood countUKBB0000041211.28
630MGLL levelsGCST9046990111.27
631Other disorders of veinsFING0000104011.26
632Pain type(s) experienced in last month - Headache | PainUKBB0000062711.26
633Arm fat mass (left) | Impedance measuresUKBB0000004311.26
634CLIP2/DAB2 ratioGCST9031412411.26
635Waist circumference | Body size measuresUKBB0000090411.25
636Leg fat-free mass (left) | Impedance measuresUKBB0000039311.24
637ABHD14B/SCRN1 ratioGCST9031314511.21
638Cereal bar likingGCST9009472811.20
639LZTFL1 levelsGCST9046983411.20
640F-healthy breakfast food liking (derived food-liking factor)GCST9009478011.20
641Immature fraction of reticulocytesGCST9000238711.20
642HypertensionGCST9046813511.19
643Red wine consumption (glasses per month) (UKB data field 1578, 4419)GCST9013298711.19
644Major dietary changes in the last 5 years - No | DietUKBB0000042111.18
645PPP1R2/TACC3 ratioGCST9031571911.17
646ITGB1BP2/TIA1 ratioGCST9031522211.16
647CD79B/ICAM3 ratioGCST9031390111.13
648GP1BA/HBEGF ratioGCST9031495611.11
649BMI (standard GWA)GCST9026726811.11
650Qualifications - None of the above | EducationUKBB0000072911.11
651Number of sexual partners in opposite-sex sexual behaviorGCST9002648111.09
652Pulmonary heart disease (PheCode 415)GCST9047594211.07
653KIF22 levelsGCST9046968211.05
654DAG1/HBEGF ratioGCST9031437611.03
655LYN/YES1 ratioGCST9031535111.01
656Frailty indexGCST9002005311.00
657Right-hemisphere visual network to pallidum white-matter structural connectivityGCST9030278410.99
658Immature reticulocyte fraction (UKB data field 30280)GCST9046807910.98
659BAX/MAX ratioGCST9031346610.98
660Immature reticulocyte fraction | Blood countUKBB0000035510.94
661Types of transport used (excluding work) - Walk | Physical activityUKBB0000087910.94
662EDAR/SERPINB1 ratioGCST9031458610.92
663ENO2/SCRN1 ratioGCST9031466810.91
664DAG1 levelsGCST9046894310.90
665SH2B3/TBL1X ratioGCST9031584110.90
666T1 FreeSurfer a2009s rh S temporal sup volumeGCST9038511010.89
667MZB1 levelsGCST9046998710.88
668Other cataract | Disorders of lensUKBB0000060210.85
669CXCL11/ITGB1BP2 ratioGCST9031433510.85
670EBAG9/MITD1 ratioGCST9031456610.83
671DSG3/FABP9 ratioGCST9031455910.82
672Erectile dysfunction [ED] (PheCode 605)GCST9047616110.81
673X-12510--2-aminooctanoic acid levelsGCST9024374810.79
674Spleen volumeGCST9001666710.79
675ITGB1BP2/MITD1 ratioGCST9031521410.78
676MEP1A levelsGCST9046988710.78
677CANT1/NUDT5 ratioGCST9031361910.78
678Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731)GCST9047624610.78
679CD40LG/SERPINE1 ratioGCST9031382610.77
680FHIT levelsGCST9046923810.76
681ESAM levelsGCST9046915210.76
682PPP1R12A/SPARC ratioGCST9031571210.75
683Trunk fat mass (UKB data field 23128)GCST9046818010.75
684Insomnia complaintsGCST00469510.75
685IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus RGCST9000436910.73
686ANGPT1 levelsGCST9046830010.72
687BDNF levelsGCST9046843710.71
688IDP dMRI ProbtrackX ISOVF ifo rGCST9000453810.69
689Pyruvate levels (UKB data field 23472)GCST9026956910.67
690Monocyte countGCST00462510.67
691Diabetes mellitus (UKB data field 2443)GCST9004362710.65
692REST UKBBICA NODEamps25 0009GCST9038549210.64
693Right-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivityGCST9030278010.64
694HBEGF/PDGFA ratioGCST9031503310.61
695Gastroesophageal reflux diseaseGCST9000051410.58
696Treatment/medication code - metformin | MedicationsUKBB0000085110.57
697EDAR/SNAP23 ratioGCST9031458710.56
698CEP20 levelsGCST9046871210.55
699CXCL5/SDC4 ratioGCST9031435310.54
700Neutrophil percentage of white cellsGCST9000239910.52
701CD84 levelsGCST9046865310.52
702Leg fat-free mass (right) | Impedance measuresUKBB0000039410.51
703Systolic blood pressureGCST9030169610.51
704Prostate cancerGCST9027471610.51
705Pain in limbFING0000113810.48
706ENO2/MGLL ratioGCST9031466310.48
707FXN/TRIAP1 ratioGCST9031489910.47
708MAP3K5/ZBTB16 ratioGCST9031538010.46
709IDP dMRI TBSS OD Pontine crossing tractGCST9000440310.46
710AARSD1/UBAC1 ratioGCST9031313510.45
711Leg predicted mass (right) | Impedance measuresUKBB0000039710.43
712VSIG10 levelsGCST9047105010.43
713FCAR levelsGCST9046919710.43
714Takes medication for Diabetes/sugar?GCST9047526810.43
715EDAR/ERBIN ratioGCST9031457510.41
716Brain age gapGCST9055803410.40
717Fasciitis (PheCode 728.7)GCST9047624410.40
718Red blood cell (erythrocyte) distribution width | Blood countUKBB0000074810.40
719Arm predicted mass (right) | Impedance measuresUKBB0000005010.39
720PAPPA levelsGCST9001203610.38
721SH2D1A levelsGCST9047061710.37
722DAG1/MGLL ratioGCST9031437710.36
723Spread type - Other type of spread/margarine | DietUKBB0000079510.35
724Follicular lymphoma, hilmo (controls excluding all cancers)FING0000054810.34
725IDP dMRI TBSS ICVF Anterior corona radiata RGCST9000434910.33
726CXCL5 levelsGCST9046893210.32
727REST UKBBICA NODEamps25 0014GCST9038549710.31
728aparc-a2009s rh volume S-oc-middle+LunatusGCST9000305510.31
729ICA1/TANK ratioGCST9031511210.30
730RETN/RNASET2 ratioGCST9031576810.28
731BMP6 levelsGCST9046845410.28
732DAPP1/PMVK ratioGCST9031439610.27
733F9/RARRES2 ratioGCST9031474910.26
734CX3CL1 levelsGCST9027477810.26
735All influenzaFING0000006410.26
736FKBP5/MITD1 ratioGCST9031484410.25
737Usual walking pace | Physical activityUKBB0000089110.25
738SMAD1 levelsGCST9047067510.24
739Forced vital capacity (FVC) | SpirometryUKBB0000025410.22
740Wegener granulomatosisFING0000144610.21
741Body mass indexGCST9042811910.20
742Age completed full time education | EducationUKBB0000001310.20
743Whole body water mass (UKB data field 23102)GCST9046818410.20
744PPCDC/RWDD1 ratioGCST9031570410.18
745Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T216ECGA00021610.17
746NCK2/PLA2G4A ratioGCST9031552410.17
747Types of physical activity in last 4 weeks - Walking for pleasure (not as a means of transport) | Physical activityUKBB0000087510.17
748ESAM/JAM2 ratioGCST9031471210.16
749APP/DAG1 ratioGCST9031332010.15
750ATP5IF1/LYN ratioGCST9031338910.14
751SERPINE1 levelsGCST9047059610.13
752ATP5IF1 levelsGCST9046839210.13
753Time to complete round | Pairs matchingUKBB0000082210.13
754HSIL lesion of the vulvaFING0000062610.12
755PCDH17 levelsGCST9047016910.12
756ATG4A/NSFL1C ratioGCST9031336810.10
757CD69/PPP1R2 ratioGCST9031388210.10
758CD300C/CLEC14A ratioGCST9031378610.09
759PCDH17/SEMA7A ratioGCST9031560510.09
760Ectopic pregnancyFING0000048710.08
761MAVS/RNF41 ratioGCST9031539510.06
762Fresh fruit consumptionGCST9013297910.05
763ALDH1A1/CA3 ratioGCST9031324410.05
764Qualifications - CSEs or equivalent | EducationUKBB0000072810.05
765NeuroticismGCST00377010.04
766EBAG9/TBCB ratioGCST9031456710.03
767Spicy food likingGCST9009484610.02
768Type 2 diabetesGCST904681519.98
769DKK1/MGLL ratioGCST903144739.98
770MPO levelsGCST900120319.98
771DNA methylation GrimAge accelerationGCST900142889.97
772Left-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivityGCST903026999.97
773SUSD1/THPO ratioGCST903158999.96
774Reticulocyte percentage (UKB data field 30240)GCST904681019.95
775NUDC levelsGCST904701029.95
776Presence of other functional implants | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000007099.95
777OSCAR/TNFRSF14 ratioGCST903155889.92
778AXL/GAS6 ratioGCST903134199.92
779BCR/FOXO1 ratioGCST903134909.90
780PCSK9 levelsGCST904281109.89
781ArthrosisFING000001119.89
782RILP/RWDD1 ratioGCST903157789.89
783Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivityGCST903026739.89
784Diabetes diagnosed by doctor | Medical conditionsUKBB000001689.89
785Moderate to vigorous physical activity levelsGCST0060979.87
786COL18A1/RETN ratioGCST903141709.86
787TREML1 levelsGCST904709619.86
788CSTB levelsGCST904688989.84
789Vascular/heart problems diagnosed by doctor - None of the above | Medical conditionsUKBB000008999.84
790Lesion of plantar nerveFING000007209.83
791ANGPT1/MPIG6B ratioGCST903132659.82
792Arm fat-free mass (right) | Impedance measuresUKBB000000489.81
793Medication for pain relief, constipation, heartburn - None of the above | MedicationUKBB000004579.81
794Alcohol drinker status - Current | AlcoholUKBB000000219.81
795CD79B/FCRL1 ratioGCST903138999.78
796SDC4/WWP2 ratioGCST903158219.78
797Disorders of synovium and tendonFING000004629.78
798LGALS8/SOD2 ratioGCST903153209.78
799SNAP23/SNAP29 ratioGCST903158559.77
800AXIN1/NFATC1 ratioGCST903134159.77
801Multi-site chronic pain | Other traitUKBB000004909.77
802Coffee intake (standard GWA)GCST902672749.76
803Sleep disorders (combined)FING000013119.76
804Omega-3 fatty acids to total fatty acids percentageGCST905024609.74
805CASP2 levelsGCST904685449.73
806Medication use (drugs used in diabetes)GCST900187619.73
807Arm predicted mass (left) | Impedance measuresUKBB000000499.72
808PDGFA/PRSS27 ratioGCST903156169.72
809POSTN levelsGCST904702889.72
810AZU1/MPO ratioGCST903134259.70
811Qualifications - Other professional qualifications eg: nursing, teaching | EducationUKBB000007329.70
812lymphocyte (fraction, minimum, inv-norm transformed)GCST904754389.70
813SNAP25 levelsGCST904706919.68
814Forced expiratory volume (baseline)GCST905658449.67
815PRTN3 levelsGCST904703489.67
816Sleeplessness / insomnia | SleepUKBB000007789.65
817Plasma cystathionine levels in chronic kidney diseaseGCST902649749.65
818EGLN1/PSIP1 ratioGCST903146209.65
819Arm fat-free mass (left) | Impedance measuresUKBB000000479.64
820Colitis, primary sclerosing, strict definitionFING000003139.63
821Illnesses of father - High blood pressure | Family historyUKBB000003439.62
822Hemoglobin A1c (HbA1c, maximum, inv-norm transformed)GCST904750919.62
823KIRREL2/PLA2G1B ratioGCST903152519.61
824Insulin pump user (PheCode 250.3)GCST904756809.61
825Alcohol usually taken with meals | AlcoholUKBB000000259.61
826Hemoglobin A1c (HbA1c, mean, inv-norm transformed)GCST904750949.58
827Leg fat percentage (right) | Impedance measuresUKBB000003929.58
828MANSC1/PODXL2 ratioGCST903153719.58
829Leisure/social activities - Other group activity | Social supportUKBB000004009.57
830EPO/TFRC ratioGCST903146849.57
831NUDT5/SERPINB1 ratioGCST903155819.55
832Neutrophill percentage (UKB data field 30200)GCST904680939.55
833CTSO levelsGCST901792779.53
834Phosphatidylinositol-O_36:0_[M-H]1- levelsGCST900604809.52
835Monocyte percentage | Blood countUKBB000004809.52
836ARHGAP1/SPARC ratioGCST903133449.52
837SERPINE1/USP8 ratioGCST903158359.51
838Mean corpuscular hemoglobin concentrationGCST900023919.50
839RGMA/RGMB ratioGCST903157699.50
840SpondyloarthritisFING000013239.49
841BCAN/NCAN ratioGCST903134819.49
842CNTN2 levelsGCST904688049.48
843Systolic blood pressure (BMI adjusted)GCST903351639.48
844Exposure to tobacco smoke outside home | SmokingUKBB000002299.47
845Cardiometabolic multimorbidityGCST902747239.47
846PF4 levelsGCST904702119.47
847Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary OperationsUKBB000005839.46
848ITGB1BP2/USP8 ratioGCST903152239.45
849RadiculopathyFING000012389.45
850ITGB1BP2/WASF1 ratioGCST903152249.45
851EPPK1 levelsGCST904691379.44
852Arthropathy in ulcerative colitisFING000001109.44
853F2R levelsGCST904691689.44
854sodium (minimum, inv-norm transformed)GCST904763979.43
855Volume of right medial nucleusGCST904750429.43
856Benign neoplasm: ChoroidFING000001709.42
857IL6ST/MARCO ratioGCST903151679.42
858DBI/EDAR ratioGCST903144089.41
859RAP1A levelsGCST904704259.41
860Type 1 diabetes (PheCode 250.1)GCST904756619.41
861TNFRSF1A levelsGCST900120159.41
862ATP5IF1/F2R ratioGCST903133849.40
863CEACAM8/PGLYRP1 ratioGCST903140039.40
864Alcohol use and misuse (confirmatory factor analysis Factor 22)GCST903093569.39
865GOLM2 levelsGCST904693769.37
866Esophagitis, GERD and related diseases (PheCode 530.1)GCST904760469.36
867CA3 levelsGCST904685129.36
868IDP dMRI ProbtrackX OD fmaGCST900044609.35
869IDP dMRI TBSS ICVF Uncinate fasciculus RGCST900043719.34
870Sciatica+with lumbagoFING000012799.34
871SERPINI1 levelsGCST904706029.34
872Non-cancer illness code, self-reported - osteoarthritis | Medical conditionsUKBB000005219.34
873IRAK1/NFATC1 ratioGCST903151949.33
874Principal component-derived dietary pattern 1GCST901330069.33
875TMSB10/TXNRD1 ratioGCST903159259.29
876aparc-Desikan lh area fusiformGCST900030799.29
877CASP3/LYN ratioGCST903136359.29
878ABHD14B/APRT ratioGCST903131379.28
879Lamb likingGCST900947909.28
880Enthesopathies of lower limb, excluding footFING000005099.28
881DNPH1/PDGFB ratioGCST903145279.27
882CD79B levelsGCST904686489.27
883CLEC1B levelsGCST904687689.27
884Obesity due to excess caloriesFING000008969.27
885SSC5D levelsGCST904707489.27
886SMAD3 levelsGCST904706779.26
887Leg fat percentage (left) | Impedance measuresUKBB000003919.25
888Mean platelet volume at deliveryGCST903022329.23
889Treatment speciality of consultant (recoded) - General medicine | Summary AdministrationUKBB000008329.23
890Diseases of male genital organsFING000004269.22
891Potassium in urine | Urine assaysUKBB000006559.22
892Basal metabolic rate | Impedance measuresUKBB000000869.20
893Symptoms concerning nutrition, metabolism, and development (PheCode 1002)GCST904755569.20
894Arm fat percentage right (UKB data field 23119)GCST904681589.20
895Hypo-osmolality and hyponatraemiaFING000006489.19
896Hip circumference | Body size measuresUKBB000003289.18
897Thyroid stimulating hormone levels within normal range in pregnancyGCST904351959.17
898Other anxiety disordersFING000009609.17
899LAT2 levelsGCST904697399.17
900Methods of admission to hospital (recoded) - Emergency admission: A&E | Summary AdministrationUKBB000004649.17
901F-lentils/beans liking (derived food-liking factor)GCST900947939.17
902DARS1 levelsGCST904689479.16
903ATP5IF1/FXN ratioGCST903133869.16
904Father's age at death | Family historyUKBB000002419.15
905IDP dMRI TBSS OD Genu of corpus callosumGCST900044049.14
906GZMB/IL15 ratioGCST903150159.13
907Arm fat percentage left (UKB data field 23123)GCST904681579.12
908APRT/PSME1 ratioGCST903133389.11
909Plasma 3-hydroxybutyroylglycine** levels in chronic kidney diseaseGCST902644889.10
910SPRY2 levelsGCST904707389.09
911PDGFA/USP8 ratioGCST903156219.08
912Red cell distribution widthGCST900024049.08
913CNST/ITGB1BP2 ratioGCST903141589.08
914lymphocyte (fraction, mean, inv-norm transformed)GCST904754359.08
915ENO1 levelsGCST904691099.07
916Blood cell traits latent factor 22 (white cell)GCST905592649.07
917CST3/RETN ratioGCST903142979.05
918SCARF1/TNFRSF14 ratioGCST903158129.04
919IPCEF1 levelsGCST904696249.03
920TRIM5 levelsGCST904709709.01
921Other peripheral nerve disorders (PheCode 351)GCST904758429.01
922IGSF8/VSIR ratioGCST903151419.00
923Basophil count varianceGCST905656829.00
924Hip circumference (UKB data field 49)GCST904681708.99
925Hand grip strength (left) | Hand grip strengthUKBB000003008.99
926Reticulocyte fraction of red cellsGCST900024068.95
927Forced expiratory volume in 1-second (FEV1) | SpirometryUKBB000002518.95
928Lymphocyte percentage of white cellsGCST0046328.94
929IPCEF1/SERPINE1 ratioGCST903151848.94
930aparc-a2009s rh thickness G-temporal-middleGCST900037148.92
931DARS1/MAP4K5 ratioGCST903144048.91
932BACH1/NFATC1 ratioGCST903134448.89
933Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivityGCST903027188.88
934Current SmokerFING000003718.88
935Mild obesity-related type 2 diabetesGCST900264158.87
936aseg lh volume CaudateGCST900026218.87
937Fluid intelligence score decline (difference score)GCST905658628.86
938CLEC1B/GP1BA ratioGCST903140918.86
939Cataract (PheCode 366)GCST900437858.86
940Glucose levelsGCST900928198.85
941ADGRF5 levelsGCST904682398.85
942Prescriptions - doxazosin | alpha1-antagonist,alpha blockerUKBB000006798.85
943IDP dMRI TBSS ISOVF FornixGCST900044828.85
944DDAH1 levelsGCST904689668.84
945Right-hemisphere somatomotor network to right-hemisphere default mode network white-matter structural connectivityGCST903027938.84
946Coffee type: Decaffeinated coffee (any type) (UKB data field 1508_1)GCST901329748.84
947Sum eosinophil basophil countsGCST0046248.83
948Diffuse idiopathic skeletal hyperostosis flow scoreGCST901345328.83
949BA-exvivo rh area BA45GCST900032298.82
950Monocyte count (UKB data field 30130)GCST904680908.82
951Mother's age | Family historyUKBB000004848.82
952PDGFB levelsGCST904701898.82
953Left-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST903027228.81
954White blood cell countGCST900023748.81
955High light scatter reticulocyte percentage (UKB data field 30290)GCST904680778.81
956Sum neutrophil eosinophil countsGCST0046138.80
957Type 2 diabetesGCST0101188.80
958ALOX15B levelsGCST906175478.80
959Granulocyte countGCST0046148.80
960monocyte (fraction, maximum, inv-norm transformed)GCST904755088.79
961CLEC1B/PPP1R2 ratioGCST903141018.78
962CLEC1B/LBR ratioGCST903140958.77
963TIMP3 levelsGCST904708718.74
964monocyte (fraction, mean, inv-norm transformed)GCST904755118.74
965Coffee type: Ground coffee (include espresso, filter etc) (UKB data field 1508_3)GCST900418038.74
966PDAP1 levelsGCST904701798.73
967TNFRSF13C levelsGCST904709068.73
968SULT1A1 levelsGCST904707818.70
969Fluid intelligence score decline (log-difference score)GCST905658528.70
970PDCD1/TNFRSF4 ratioGCST903156098.70
971Type 2 diabetesGCST900187068.70
972Vegetables likingGCST900948628.70
973PLIN3/VSIR ratioGCST903156798.70
974SDC4/SMAD1 ratioGCST903158208.70
975SERPINH1 levelsGCST904706018.69
976Hereditary ataxiaFING000006108.69
977Red blood cell erythrocyte distribution width (UKB data field 30070)GCST904680998.69
978PEAR1/SCARF1 ratioGCST903156428.68
979BCR/ICA1 ratioGCST903134938.68
980Age-related eyesight deterioration (confirmatory factor analysis Factor 27)GCST903093618.68
981Neutrophill percentage | Blood countUKBB000004988.67
982TFPI2 levelsGCST904708388.67
983KIFBP/LYN ratioGCST903152468.67
984DKK1/VTA1 ratioGCST903144858.66
985ANXA3/BID ratioGCST903132798.65
986Ankylosing spondylitisFING000000898.65
987S100A11/S100A12 ratioGCST903157988.64
988PPP1R12A/VEGFC ratioGCST903157158.64
989F8 levelsGCST902407258.63
990IDP dMRI TBSS MD Posterior thalamic radiation RGCST900040558.63
991Sum basophil neutrophil countsGCST0046208.62
992Mean time to correctly identify matches | Reaction timeUKBB000004538.62
993Ever highly irritable/argumentative for 2 days | Mental healthUKBB000002198.62
994DBNL/EDAR ratioGCST903144168.61
995GHRL levelsGCST904693418.60
996aseg global volume 3rd-VentricleGCST900025998.59
997LAT/PDGFA ratioGCST903152858.59
998METAP1D/PLXNA4 ratioGCST903154278.58
999Glucose (fasting status unknown, maximum, inv-norm transformed)GCST904753298.58
1000IPCEF1/TBCB ratioGCST903151878.57